Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.77+0.03 (+1.09%)
Close on Nov 16, 2026Market cap $23.10MP/E –Yield –
Evaxion A/S operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -122.7%, against -440.6% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -122.7% | +317.9 |
| FY2024 | Dec 31, 2024 | -440.6% | +29966.3 |
| FY2023 | Dec 31, 2023 | -30406.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -11729.7% | – |
| Q2 FY2024 | Jun 30, 2024 | -2974.7% | – |
See a number that looks wrong?